There (AK7) Fair Value & Analysis
Other · DE · Market cap €288M
Fair value as of: Jul 14, 2026
From 13 valuation models · updated 27 days ago
Share price −11.0% over the past month.
Below-average quality, and screening another 42% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (€0.6500). The favourable scenario is already priced in.
- Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (€0.3500 to €0.6500) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.
How to read this chart
60‑month range €0.4370 – €1.14 · fair‑value band €0.3500 – €0.6500 · the €0.8615 price screens above the €0.5000 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 14, 2026.
Analysis
There (AK7) currently trades at €0.8615, while our model-based Fair Value estimate is €0.5000, implying the stock looks roughly 42.0% overvalued today. The Quality Score stands at 31/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Our scenario range runs from €0.3500 (bear case) to €0.6500 (bull case); at €0.8615, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 28% above its 52-week low, currently above its 200-day average. For context, the median of 10 Other peers we cover trades at -22% fair-value upside, at -42%, AK7 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Multiples (€0.9000) versus Economic Profit (€0.4800). Highest evidence: ROIC Compounder (72).
Notify me when AK7 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Quality Score breakdown
Of which business quality 33 · Market factors (momentum, volatility) 50
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
There is no Profile data available for AK7.BE.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
There reported revenue of €173M in FY2024 versus €72.5M in FY2020, a compound +24.3%/yr. Reported net income was €17.7M in FY2024, compounding +8.5%/yr from FY2020.
AK7 screens 42% overvalued. Compare with Federal Home Loan Mortgage Corporation →
Peer Group
Other · 369 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.84 | $52.77 | +233% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹191.93 | -87% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
| 540777 540777 | ₹567.55 | ₹142.69 | -75% |
| Lupin Limited 500257 | ₹2,476 | ₹1,983 | -20% |
| 540719 540719 | ₹1,788 | ₹850.02 | -52% |
| 524804 524804 | ₹1,620 | ₹1,268 | -22% |
| 540716 540716 | ₹1,612 | ₹1,224 | -24% |
| Eicher Motors Limited 505200 | ₹7,340 | ₹6,859 | -7% |
Compare There with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is There (AK7) overvalued or undervalued?
What is the fair value of AK7?
What is the quality score of AK7?
What is the net profit margin of AK7?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track There and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.